COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,313 Articles (22,772 medRxiv, 8,541 bioRxiv)

Most recent first Previous |  Page 1702: Articles 17011-17020  | Next

The Spike-specific IgA in milk commonly-elicited after SARS-Cov-2 infection is concurrent with a robust secretory antibody response, exhibits neutralization potency strongly correlated with IgA binding, and is highly durable over time
Fox, A., Marino, J., Amanat, F., Oguntuyo, K. Y., Hahn-Holbrook, J., Lee, B., Krammer, F., Zolla-Pazner, S., Powell, R. L.
10.1101/2021.03.16.21253731 — Posted: 2021-03-20 Discussion: Offsite
"This is about the coolest thing I've ever seen is that you just showed right up." COVID-19 testing and vaccine acceptability among homeless-experienced adults: Qualitative data from two samples
Knight, K. R., Duke, M. R., Carey, C. A., Pruss, G., Garcia, C. M., Lightfoot, M., Imbert, E., Kushel, M. B.
10.1101/2021.03.16.21253743 — Posted: 2021-03-20
The effect of in-person primary and secondary school instruction on county-level SARS-CoV-2 spread in Indiana
Bosslet, G. T., Jang, J. J., Roll, R., Sperling, M., Khan, B.
10.1101/2021.03.17.21250449 — Posted: 2021-03-20
Persistence and detection of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance
Perez-Saez, J., Zaballa, M.-E., Yerly, S., Andrey, D. O., Meyer, B., Eckerle, I., Balavoine, J. F., Chappuis, F., Pittet, D., Trono, D., Kherad, O., Vuilleumier, N., Kaiser, L., Guessous, I., Stringhini, S., Azman, A. S., Specchio-COVID19 Study Group
10.1101/2021.03.16.21253710 — Posted: 2021-03-20
Epitope-resolved serology test differentiates the clinical outcome of COVID-19 and identifies defects in antibody response in SARS-CoV-2 variants
Voss, C., Esmail, S., Liu, X., Knauer, M., Ackloo, S., Kaneko, T., Lowes, L., Stogios, P., Seitova, A., Hutchinson, A., Yusifov, F., Skarina, T., Evdokimova, E., Loppnau, P., Ghiabi, P., Haijian, T., Zhong, S., Abdoh, H., Hedley, B., Bhayana, V., Martin, C., Slessarev, M., Chin-Yee, B., Fraser, D., Chin-Yee, I., Li, S.
10.1101/2021.03.16.21253716 — Posted: 2021-03-20
Household transmission of SARS-CoV-2 R.1 lineage with spike E484K mutation in Japan
Hirotsu, Y., Omata, M.
10.1101/2021.03.16.21253248 — Posted: 2021-03-20
Evidence for antibody as a protective correlate for COVID-19 vaccines
Earle, K. A., Ambrosino, D. M., Fiore-Gartland, A., Goldblatt, D., Gilbert, P. B., Siber, G. R., Dull, P., Plotkin, S. A.
10.1101/2021.03.17.20200246 — Posted: 2021-03-20 Discussion: Onsite
Learning from the Experiences of COVID-19 Survivors: A Descriptive Study
Prioleau, T.
10.1101/2021.03.17.21253728 — Posted: 2021-03-20
Intensity of COVID-19 in care homes following Hospital Discharge in the early stages of the UK epidemic
Hollinghurst, J., North, L., Emmerson, C., Akbari, A., Torabi, F., Lyons, R. A., Hawkes, A. G., Bennett, E., Gravenor, M. B., Fry, R.
10.1101/2021.03.18.21253443 — Posted: 2021-03-20
Mental health of patients with mental illness during the COVID-19 pandemic lockdown: A questionnaire-based survey weighted for attrition
Kolbaek, P., Hougaard Jefsen, O., Speed, M., Dinesen Ostergaard, S.
10.1101/2021.03.13.21253363 — Posted: 2021-03-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).